Melanoma, Skin cancer
Results
Phase 2
This study looked at taking tissue samples to check how pembrolizumab was working at certain time points during treatment. The study is for people whose cancer has spread to another part of the body (advanced melanoma).
Recruitment start: 14 July 2016
Recruitment end: 20 July 2017
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Dr James Larkin
Cancer Research UK London Research Institute
Merck Sharp Dohme
The Royal Marsden NHS Foundation Trust
University College London Cancer Institute
Last reviewed: 15 Mar 2024
CRUK internal database number: 12710
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
What to ask your doctor about clinical trials.
Meet and chat to other cancer people affected by cancer.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
